DAM
FATE icon

Doheny Asset Management’s Fate Therapeutics FATE Stock Holding History

Doheny Asset Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$224K Hold
5,780
– – 0.16% 77
2021
Q4 		$338K Sell
5,780
-450
-7% -$25.5K 0.24% 67
2021
Q3 		$369K Sell
6,230
-470
-7% -$36.9K 0.26% 69
2021
Q2 		$581K Hold
6,700
– – 0.37% 65
2021
Q1 		$552K Sell
6,700
-1,150
-15% -$110K 0.37% 64
2020
Q4 		$714K Buy
7,850
+180
+2% +$11.2K 0.5% 54
2020
Q3 		$307K Hold
7,670
– – 0.25% 78
2020
Q2 		$263K Sell
7,670
-16,530
-68% -$493K 0.25% 78
2020
Q1 		$474K Hold
24,200
– – 0.38% 64
2019
Q4 		$474K Sell
24,200
-50
-0.2% -$794 0.38% 64
2019
Q3 		$377K Sell
24,250
-3,300
-12% -$63.3K 0.33% 71
2019
Q2 		$559K Buy
27,550
+100
+0.4% +$1.8K 0.47% 57
2019
Q1 		$482K Sell
27,450
-8,810
-24% -$139K 0.41% 61
2018
Q4 		$465K Buy
36,260
+4,325
+14% +$60.3K 0.34% 60
2018
Q3 		$520K Buy
31,935
+2,300
+8% +$27.2K 0.27% 71
2018
Q2 		$336K Buy
29,635
+145
+0.5% +$1.6K 0.18% 82
2018
Q1 		$288K Buy
29,490
+15,490
+111% +$148K 0.15% 91
2017
Q4 		$86K Buy
+14,000
New +$62.5K 0.04% 108

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Doheny Asset Management's FATE Position: Q1 2022 in Review

Doheny Asset Management held its Fate Therapeutics (FATE) position steady in Q1 2022 at 5,780 shares worth $224K. The position accounts for 0.16% of the portfolio, ranked #77.

Doheny Asset Management first reported a position in FATE in Q4 2017 and has held it in 18 quarters since. The position peaked at $714K in Q4 2020. 250 funds tracked by Wall St. Rank hold FATE as of Q1 2022.

  • Doheny Asset Management held 5,780 shares of Fate Therapeutics worth $224K as of Q1 2022.
  • Doheny Asset Management left its Fate Therapeutics share count unchanged in Q1 2022.
  • Fate Therapeutics made up 0.16% of Doheny Asset Management's portfolio in Q1 2022, its #77 holding.
  • Doheny Asset Management first reported a position in Fate Therapeutics in Q4 2017 and has held it in 18 quarters since.
  • Doheny Asset Management's Fate Therapeutics position peaked at $714K in Q4 2020.
  • 250 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2022.

Based on Doheny Asset Management's 13F filing for Q1 2022, filed 16 May 2022.